IP Verse

Green Cross competitive analysis

Loading summary...

Explore patent oppositions filed by Green Cross against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 23, 2025

Patent Number	Title	Applicant	Opposition Date
Get instant updates on new opposition filings by the company
EP3626258	Methods And Compositions For Cns Delivery Of Iduronate-2-Sulfatase	SHIRE HUMAN GENETIC THERAPIES	May 3, 2022
EP3103469	Cns Delivery Of Therapeutic Agents	SHIRE HUMAN GENETIC THERAPIES	Sep 9, 2021

Explore the latest publications and patents granted to Green Cross, showcasing their recent innovations and technological advancements.

Discover the latest PTAB cases involving Green Cross, highlighting their recent legal challenges and patent disputes.

Last updated on: Oct 22, 2025

Proceeding Number	Filing Date	Petitioner	Respondent	Status
Get alerts for PTAB Cases involving Green Cross
IPR2016-00258	Nov 25, 2015	GREEN CROSS	SHIRE HUMAN GENETIC THERAPIES	Final Written Decision

IP litigation analysis comparing Green Cross with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced
GREEN CROSS	2	-	1	-
SHIRE HUMAN GENETIC THERAPIES	3	14	-	1
TAKEDA PHARMACEUTICAL	1	21	-	1